A new drug delivery system with controlled release of antibiotic only in the presence of infection

Journal of Biomedical Materials Research

Volumn 42, Issue 1, 1998, Pages 112-116

  Suzuki, Yoshihisa ^a   Tanihara, Masao ^b   Nishimura, Yoshihiko ^a   Suzuki, Kyoko ^a   Kakimaru, Yoshimi ^c   Shimizu, Yasuhiko ^d  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c KURARAY CO LTD   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Antibiotic; Drug delivery system; Drug polymer conjugate; Infection; Occlusive dressing

Indexed keywords

ANTIBIOTICS; HYDROGELS; POLYVINYL ALCOHOLS; PROTEINS;

OCCLUSIVE DRESSING;

CONTROLLED DRUG DELIVERY;

GENTAMICIN; POLYVINYL ALCOHOL; PROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; HYDROGEL; HYDROLYSIS; MALE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RAT; STRAIN DIFFERENCE; WOUND DRESSING;

EID: 0032189462     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199810)42:1<112::AID-JBM14>3.0.CO;2-N     Document Type: Article

References (22)

1. F. R. DiMaio, J. J. O'Halloran, and J. M. Quäle, "In vitro elution of ciprofloxacin from polymethylmethacrylate cement beads," J. Orthop. Res., 12, 79-82 (1994).
2. D. S. Dünn, S. Raghavan, and R. G. Volz, "Gentamicin sulfate attachment and release from anodized T1-6A1-4V orthopedic materials," J. Bioined. Mater. Res., 27, 895-900 (1993).
3. T. N. Gerhart, R. D. Roux, P. A. Hanff, G. L. Horowitz, W. C. Renshaw, and W. C. Hayes, "Antibiotic-loaded biodegradable bone cément from prophylaxis and treatment of experimental osteomyelitis in rats," J. Orthop. Res., 11, 250-255 (1993).
4. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, "Biodegradable long-circulating polymeric nanospheres," Science, 263,1600-1603 (1994).
5. O. F. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. S. Jones, and S. D. Putney, "A month-long effect from a single injection of microencapsulated human growth hormone," Nature Med., I, 795-799 (1996).
6. R. Langer, "New methods of drug delivery," Science, 249, 1527-1533 (1990).
7. E. Mathiowitz, J. S. Jacob, Y. S. Jong, P. C. Gerardo, D. E. Chickerling, P. Chaturvedi, C. A. Santos, K. Vijayaraghavan, S. Montgomery, M. Bassett, and C. Morrell, "Biologically erodable microspheres as potential oral drug delivery system," Nature, 386, 410-414 (1997).
8. C. L. Nelson, S. G. Hickmon, and B. H. Harrison, "Elution characteristics of gentamicine-PMMA beads after implantation in humans," Orthopedics, 17, 415-416 (1994).
9. J. S. Price, A. F. Tencer, D. M. Arm, and G. A. Bohach, "Controlled release of antibiotics from coated orthopedic implants," J. Biomed. Mater. Res., 30, 281-286 (1996).
10. E. C. Robb and P. Nathan, "Control of experimental burn wound infections: Comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing," J. Trauma, 21, 889-893 (1981).
11. C. H. Self and S. Thompson, "Light activatable antibodies: Models for remotely activatable proteins," Nature Med., 2,817820(1996).
12. G. VVei, Y. Kotoura, M. Oka, T. Yamamuro, R. Wada, S. Hyon, and Y. Ikada, "A bioabsorbable delivery system for antibiotic treatment of osteomyelitis," J. Bone Joint Surg., 73B, 246-252 (1991).
13. J. F. Acar, "Problems and changing patterns of resistance with gram-negative bacteria," Rev. Infect. Dis., 7, 545-551 (1985).
14. B. B. Finlay and P. Cossart, "Exploitation of mammalian host cell functions by bacterial pathogens," Science, 276, 718-725 (1997).
15. H. S. Gold and R. C. Moellering, Jr., "Antimicrobial-drug resistance," N. Engl. ]. Med., 335,1445-1453 (1996).
16. C. M. Hayward and G. E. Griffin, "Antibiotic resistance: The current position and the molecular mechanisms involved," Er. ]. Hasp. Med., 52, 473-478 (1994).
17. G. Rodeheaver, D. P. Pettry, V. Turnbull, M. T. Edgerton, and R. F. Edlich, "Identification of the wound infectionpotentiating factors in soil," Am. J. Surg., 128, 8-14 (1974).
18. T. Morita, H. Kato, S. Iwanaga, K. Takada, and T. Kimura, "New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase," J. Biocheni., 82,1495-1498 (1977).
19. M. Tanihara, Y. Suzuki, Y. Nishimura, K. Suzuki, Y. Kakimaru, "Thrombin-sensitive peptide linkers for biological signalresponsive drug release systems," Peptides, 19, 421-425 (1998).
20. M. Zhang, Z. Zou, M. Maass, and R. Sager, "Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level," Cancer Res., 55, 2537-2541 (1995).
21. R. Khokha, D. C. Martin, and J. E. Fata, "Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors," Cancer Metast. Rev., 14, 97-111 (1995).
22. D. A. Putnam, J. G. Shiah, and J. Kopecek, "Intracellularly biorecognizable derivatives of 5-fluorouracil," Biochem. Plmnnacol, 52, 957-962 (1996).